The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine
Open accessAbstract
A grand challenge impeding optimal treatment outcomes for patients with cancer arises from the complex nature of the disease: the cellular heterogeneity, the myriad of dysfunctional molecular and genetic networks as results of genetic (somatic) and environmental perturbations. Systems biology, with its holistic approach to understanding fundamental principles in biology, and the empowering technologies in genomics, proteomics, single-cell analysis, microfluidics and computational strategies, enables a comprehensive approach to medicine, which strives to unveil the pathogenic mechanisms of diseases, identify disease biomarkers and begin thinking about new strategies for drug target discovery. The integration of multidimensional high-throughput 'omics' measurements from tumour tissues and corresponding blood specimens, together with new systems strategies for diagnostics, enables the identification of cancer biomarkers that will enable presymptomatic diagnosis, stratification of disease, assessment of disease progression, evaluation of patient response to therapy and the identification of reoccurrences. Whilst some aspects of systems medicine are being adopted in clinical oncology practice through companion molecular diagnostics for personalized therapy, the mounting influx of global quantitative data from both wellness and diseases is shaping up a transformational paradigm in medicine we termed 'predictive', 'preventive', 'personalized', and 'participatory' (P4) medicine, which requires new strategies, both scientific and organizational, to enable bringing this revolution in medicine to patients and to the healthcare system. P4 medicine will have a profound impact on society - transforming the healthcare system, turning around the ever escalating costs of healthcare, digitizing the practice of medicine and creating enormous economic opportunities for those organizations and nations that embrace this revolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This strategy integrates genomic sequencing, blood-based omics (e.g., metabolomics and proteomics), microbiome analysis, and wearable device data to capture each patient’s unique biological state over time.”
From Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery (2025) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Flagged first, then by citations
Research works printed but not linked: 1
- Price ND, 2009, Genomic and Personalized Medicine: From Principles to Practice, 131
Cited by
Sorted by citations
Items 101–200 of 224
CFTR Protein Repair Therapy in Cystic Fibrosis
Quintana‐Gallego, E., Delgado‐Pecellín, I., & Acuña, C. C. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.03.002 · Cited by 13
Azad, A. K., Lloyd, C., Sadée, W., & Schlesinger, L. S. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00139 · Cited by 12
Stochastic models for single‐cell data: Current challenges and the way forward
Hsu, I. S., & Moses, A. M. (2021) · FEBS Journal · doi:10.1111/febs.15760 · Cited by 13
Network controllability solutions for computational drug repurposing using genetic algorithms
Popescu, V., Kanhaiya, K., Năstac, I., Czeizler, E., & Petre, I. (2022) · Scientific Reports · doi:10.1038/s41598-022-05335-3 · Cited by 16
Tratamientos reparadores de la proteína CFTR en la fibrosis quística
Quintana‐Gallego, E., Delgado‐Pecellín, I., & Acuña, C. C. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.07.013 · Cited by 13
Oncoproteomics: Trials and tribulations
Zhou, L., Li, Q., Wang, J., Huang, C., & Nice, E. C. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500081 · Cited by 13
IFPA award in placentology lecture: Phylogenomic origins and evolution of the mammalian placenta
Wildman, D. E. (2016) · Placenta · doi:10.1016/j.placenta.2016.04.004 · Cited by 13
Toponome imaging system: multiplex biomarkers in oncology
Evans, R. G., Naidu, B. V., Rajpoot, N., Epstein, D. B. A., & Khan, M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.003 · Cited by 11
Cheema, A. K., Asara, J. M., Wang, Y., Neubert, T. A., Tolstikov, V., & Turck, C. W. (2015) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.15-2603-001 · Cited by 11
A decade of Systems Biology: where are we and where are we going to?
Peitsch, M. C., & de Graaf, D. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.002 · Cited by 11
Perrier, A., Hainaut, P. L., Guenoun, A., Nguyen, D.-P., Lamy, P., Guerber, F., Troalen, F., Denis, J. A., & Boissan, M. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2021.12.005 · Cited by 10
Systems Biology Through the Concept of Emergence
Kolodkin, A. N. (2016) · History, philosophy and theory of the life sciences · doi:10.1007/978-3-319-47000-9_17 · Cited by 9
Bizzarri, N., Nero, C., Sillano, F., Ciccarone, F., D’Oria, M., Cesario, A., Fragomeni, S. M., Testa, A. C., Fanfani, F., Ferrandina, G., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm12010003 · Cited by 9
Radder, J. E., Shapiro, S. D., & Berndt, A. (2014) · Personalized Medicine · doi:10.2217/pme.14.51 · Cited by 9
Tenenbaum, J. D., James, A., & Paulyson-Nuñez, K. (2012) · Journal of Personalized Medicine · doi:10.3390/jpm2040192 · Cited by 9
Genomic Biomarkers For Patient Selection And Stratification: The Cancer Paradigm
Moschos, S. A. (2012) · Bioanalysis · doi:10.4155/bio.12.241 · Cited by 9
The application of human tissue for drug discovery and development
Clotworthy, M. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.689282 · Cited by 10
Biomarker validation is still the bottleneck in biomarker research
Diamandis, E. P. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02579.x · Cited by 9
Managing Large-Scale Genomic Datasets and Translation into Clinical Practice
Soualmia, L. F., Thierry Lecroq, B., & Informatics, S. E. F. T. I. Y. S. O. B. A. T. (2014) · Yearbook of Medical Informatics · doi:10.15265/iy-2014-0039 · Cited by 8
Does circadian rhythm influence gastrointestinal toxicity?
Hofmeister, E. N., Fisher, S. E., Palesh, O. G., & Innominato, P. F. (2020) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000498 · Cited by 8
Principles of Personalized Oncology
Jain, K. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-62080-6_19 · Cited by 7
The Outcomes of Scientific Debates Should Be Published: The Arivale Story
Fiala, C., & Diamandis, E. P. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa110 · Cited by 8
Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis
Yücel, M., Önder, A., Kurt, T., Keles, B., Beyaz, M., Karadağ, Y., Yaşyerli, İ., Celik, A. I., Sema, F., Tetik, S., et al. (2025) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2025.100651 · Cited by 10
Patient-centered drug discovery as the means to improved R&D productivity
Raoof, A. A., & Aerssens, J. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.04.002 · Cited by 7
Systems approach to identify environmental exposures contributing to organ-specific carcinogenesis
States, J. C., Ouyang, M., & Helm, C. W. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.03.005 · Cited by 7
Lee, S. H., Yim, S. Y., Shim, J., & Lee, J. (2019) · Molecular and translational medicine · doi:10.1007/978-3-030-21540-8_6 · Cited by 7
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
Kuno, M., Osumi, H., Udagawa, S., Yoshikawa, K., Ooki, A., Shinozaki, E., Ishikawa, T., Oba, J., Yamaguchi, K., & Sakurada, K. (2025) · Current Oncology · doi:10.3390/curroncol32110588 · Cited by 7
Polymorphisms in Pharmacogenetics of Personalized Cancer Therapy
Calibasi‐Kocal, G., & Baskın, Y. (2017) · InTech eBooks · doi:10.5772/intechopen.69207 · Cited by 6
Telehealth’s Role Enabling Sustainable Innovation and Circular Economies in Health
Kalogeropoulos, D. (2023) · Telehealth and Medicine Today · doi:10.30953/thmt.v8.409 · Cited by 6
Studying Cellular Signal Transduction with OMIC Technologies
Landry, B. D., Clarke, D. C., & Lee, M. J. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.07.021 · Cited by 8
From Genome Sequencing to Bedside
Soualmia, L. F., & Thierry Lecroq, B. (2013) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1638852 · Cited by 6
Appels, R., Barrero, R. A., & Bellgard, M. (2012) · Functional & Integrative Genomics · doi:10.1007/s10142-012-0270-7 · Cited by 8
Label-Free Microcavity Biosensors: Steps towards Personalized Medicine
Amarie, D., & Glazier, J. A. (2012) · Sensors · doi:10.3390/s121217262 · Cited by 6
Bieber, T. R. M., & Broich, K. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1841-z · Cited by 6
Georgiou, G., Wakefield, C. E., McGill, B. C., Fardell, J. E., Signorelli, C., Hanlon, L. V., Tucker, K., Patenaude, A. F., & Cohn, R. J. (2016) · Cancer · doi:10.1002/cncr.30119 · Cited by 6
Big Data Analytics in Healthcare
Matengo, W., Otsieno, E., & Wanjiru, K. (2020) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-030-49815-3_15 · Cited by 6
Miller, C. S., Qi, Y., Kirakodu, S. S., Ebersole, J. L., & Zhang, X. D. (2025) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70049 · Cited by 5
P4 Medicine and Pediatric Occupational Therapy
Persch, A. C., Braveman, B. H., & Metzler, C. A. (2013) · American Journal of Occupational Therapy · doi:10.5014/ajot.2013.674002 · Cited by 5
Bertrand, J., Iorio, M. D., & Balding, D. J. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000127 · Cited by 5
An IT Architecture for Systems Medicine
Ganzinger, M., Gietzelt, M., Karmen, C., Daniel, F., & Petra, K. (2015) · Studies in health technology and informatics · doi:10.3233/978-1-61499-512-8-185 · Cited by 5
Genes to Personalized Medicine
Trent, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381451-7.00001-3 · Cited by 5
Digitale Gesundheit: Was ändert sich für den Gesundheitsbegriff?
Wieser, B. (2019) · Österreichische Zeitschrift für Soziologie · doi:10.1007/s11614-019-00389-6 · Cited by 5
Özdemir, V., Burke, W., Khoury, M. J., Knoppers, B. M., & Zimmern, R. L. (2015) · doi:10.1093/med/9780199661756.003.0010 · Cited by 5
Chemical kinetic mechanistic models to investigate cancer biology and impact cancer medicine
Stites, E. C. (2013) · Physical Biology · doi:10.1088/1478-3975/10/2/026004 · Cited by 5
Seijo, E., Lima, D., Iriabho, E., Almeida, J. S., Monico, J., Echeverri, M., Gutiérrez, S., Flores, I., Lee, J., Fisher, K. J., et al. (2016) · Cancer Control · doi:10.1177/107327481602300409 · Cited by 5
Network Modelling Methods for Precision Medicine
Nushi, E., Popescu, V., Martín, J. R., Ivanov, S., Czeizler, E., & Petre, I. (2022) · doi:10.1002/9781119716600.ch10 · Cited by 5
Gibb, M., Winter, H., Komarzynski, S., Wreglesworth, N. I., & Innominato, P. F. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221123525 · Cited by 4
Systems Medicine and the Emergence of Proactive P4 Medicine
Hood, L., Flores, M. A., Brogaard, K., & Price, N. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00023-x · Cited by 3
Self-citationRETRACTED ARTICLE: Precision Medicine: The Future Management of Geriatric Conditions
Fougère, B., Morley, J. E., Arai, H., Bauer, J. M., Bernabei, R., Cherubini, A., Dong, B., Martin, F. C., Flicker, L. A., Merchant, R. A., et al. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1045-1 · Cited by 4
RetractedBlood metabolome analysis for creating a digital image of a healthy person
Trifonova, O. P., Balashova, E. E., Maslov, D. L., Grigoriev, A. I., Lisitsa, A., Ponomarenko, E. A., & Archakov, A. I. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603216 · Cited by 5
André, A., & Vignaux, J.-J. (2018) · Health informatics · doi:10.1007/978-3-319-98216-8_5 · Cited by 4
Wheat Grain Proteomics for the Food Industry
Juhász, A., Moolhuijzen, P., Bellgard, M., Appels, R., & Békés, F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5626-1_19 · Cited by 4
Research and application of omics and artificial intelligence in cancer
Zhang, Y., Ma, W., Huang, Z., Liu, K., Feng, Z., Zhang, L., Li, D., Mo, T., & Liu, Q. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad6951 · Cited by 3
Kim, Y., & Rho, H.-L. (2018) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2018.13.1.39 · Cited by 3
Personalizing Pancreatic Cancer Medicine: What are the Challenges?
Danielsson, K., Ansari, D., & Andersson, R. E. (2012) · Personalized Medicine · doi:10.2217/pme.12.111 · Cited by 3
Systems Biology: Unravelling Molecular Complexity in Health and Disease
Cheema, A. K., Fiandaca, M. S., Mapstone, M. E., & Federoff, H. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-26221-5_2 · Cited by 3
Targeting PI3K/AKT/mTOR Pathway
Criscitiello, C., & Curigliano, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_67 · Cited by 3
Identifying efficient controls of complex interaction networks using genetic algorithmsPreprint
Popescu, V., Kanhaiya, K., Năstac, I., Czeizler, E., & Petre, I. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.04853 · Cited by 3
Role of AI and Digital Twin in Smart Manufacturing
Anand, M., Sheeba, T. M., & Fancy, C. (2024) · Wiley eBooks · doi:10.1002/9781394303601.ch11 · Cited by 3
Liu, J., Zheng, C., & Wang, Y. (2014) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.10000e50 · Cited by 2
Jain, K. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9245-0_16 · Cited by 3
Nalbantoğlu, S., & Amri, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817532-3.00006-2 · Cited by 2
Personalized Therapy of Cancer
Jain, K. K. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2553-7_10 · Cited by 2
van der Stel, J. C. (2015) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0859-0_1 · Cited by 2
Hall, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-59856-7_1 · Cited by 2
A Systems Bioinformatics Approach to Interconnect Biological Pathways
Minadakis, G., & Spyrou, G. M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0822-7_17 · Cited by 2
Dammann, O., & Smart, B. T. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-96307-5_7 · Cited by 2
Dréno, B., Gallo, R. L., Berardesca, E., & Griffiths, C. E. M. (2022) · European Journal of Dermatology · doi:10.1684/ejd.2022.4236 · Cited by 2
Network modeling methods for precision medicinePreprint
Nushi, E., Popescu, V., Martín, J. Á. S., Ivanov, S., Czeizler, E., & Petre, I. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2104.09206 · Cited by 2
Precision medicine to personalize medicine in allergic airway disease
Kim, J. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000976 · Cited by 1
Hematological Malignancies in the Omics Era
Mohammad, R. M., & Azmi, A. S. (2012) · Journal of Blood & Lymph · doi:10.4172/2165-7831.1000e106 · Cited by 1
The Promise of Single Cell Omics for Onco-therapy
Azizi, E. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000121 · Cited by 1
Comparison of the experimental methods in haplotype sequencing via next generation sequencing
Tu, J., Lü, N., Duan, M., Ju, A., Sun, X. S., & Lu, Z. (2016) · Quantitative Biology · doi:10.1007/s40484-016-0068-z · Cited by 1
Fadda, M., Jobin, A., Blasimme, A., Tzovaras, B. G., Ball, M. P., & Vayena, E. (2018) · JMIR Research Protocols · doi:10.2196/10939 · Cited by 1
Srivastava, N., & Saxena, V. (2019) · Journal of Natural Remedies · doi:10.18311/jnr/2019/23584 · Cited by 1
Implantogenomic: Conceptualizing Osseointegration toward Personalized Dental Implant Therapy
Refai, A. K. (2023) · Dentistry · doi:10.5772/intechopen.109159 · Cited by 1
Multimodel Approach to Forecasting Nonlinear Nonstationary Processes in Optimal Control Problems
Minitaeva, A. M. (2024) · International Youth Conference on Radio Electronics, Electrical and Power Engineering (REEPE) · doi:10.1109/reepe60449.2024.10479796 · Cited by 1
Systems Biology Approaches for Cancer Biology
Dutta, B., Lahiri, D., Nag, M., Sarkar, N., Ray, R. R., & Bhattacharya, D. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_21 · Cited by 1
Habti, W. E., & Azmani, A. (2025) · Applied Computer Science · doi:10.35784/acs_6670 · Cited by 1
Skinner‐Taylor, C. M., Erhard-Ramírez, A., Garza‐Elizondo, M. A., Esquivel‐Valerio, J. A., Abud‐Mendoza, C., Martínez‐Martínez, M. U., Vega‐Morales, D., & Arana-Guajardo, A. (2016) · Reumatología Clínica · doi:10.1016/j.reuma.2016.03.006 · Cited by 1
Mathematical Models in Stem Cell Differentiation and Fate Predictability
Eby, W. M., & Coleman, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-27583-3_6 · Cited by 1
Roterman-Konieczna, I. (2020) · De Gruyter eBooks · doi:10.1515/9783110667219 · Cited by 1
Mass spectrometry-based proteomics and peptidomics for systems biology and biomarker discovery
Cunningham, R., Ma, D., & Li, L. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1128-z · Cited by 1
Promising Biomarkers for Early Diagnosis and Prognosis Prediction
Sloan, P., & Robinson, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-63234-2_1 · Cited by 1
Vera, J., Wolkenhauer, O., & Schmitz, U. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025237 · Cited by 1
Franco, I. C. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
‐Omics and Clinical Data Integration
Sanctis, G. D., Colombo, R., Damiani, C., Sacco, E., & Vanoni, M. (2018) · Wiley eBooks · doi:10.1002/9781119183952.ch15 · Cited by 1
Design and evaluation of a genomics variant analysis pipeline using GATK Spark toolsPreprint
Tucci, N., Cała, J., Steyn, J. S., & Paolo Missier, B. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1806.00788 · Cited by 1
Mukerji, M. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.15.pr6 · Cited by 1
Reduktionismus und Rückübertragung
Grüneberg, P. (2012) · Brennpunkt Doping · doi:10.14361/transcript.9783839420157.227
Impact of Genomics and Personalised Medicine on Current Practice of Clinical Cardiology
Gunaruwan, P. (2014) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2014.01.00020
Methodological Approaches towards Personalised Cancer Medicine
Mints, M. (2015) · Figshare
Rahmim, A., Schmidtlein, C. R., Jackson, A., Marcus, C. V., Ashrafinia, S., Soltani, M., & Subramaniam, R. M. (2014) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmic.2014.7430839
Novel insights into the genetic basis of chronic obstructive pulmonary disease
Radder, J. E. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Characterizing and analyzing disease-related omics data using network modeling approaches
Wang, C. (2014) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Fernandes, M., Cisek, K. K., & Husi, H. (2018) · doi:10.1002/9781119183952.ch20
A Vision for Twenty‐First Century Healthcare
Hood, L., Brogaard, K., & Price, N. D. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm142
Self-citationIkehara, Y., Miyoshi, E., Kizuka, Y., & Yamaguchi, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-5856-2_15
Popovici, R. M., Cărăuleanu, A., Lazar, I. T., Petroaie, A. D., Pangal, A., Grigore, M., & Eşanu, I. (2020) · Revista de Chimie · doi:10.37358/rc.19.12.7789
Metadata
- Authors
- Tian, Q., Price, N. D., & Hood, L.
- Affiliations
- Institute for Systems Biology (US)
- Corresponding author
- Tian, Q.
- Hood, L.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2012-01-17
- Volume
- 271
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- PMC
- PMC3978383
- OpenAlex
- W2118104220
- Cited by
- 224
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 10 · 2021: 12 · 2020: 15 · 2019: 10 · 2018: 19 · 2017: 14 · 2016: 17 · 2015: 21 · 2014: 25 · 2013: 21 · 2012: 29
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (U54 CA151819A)
- National Cancer Institute (U54 CA151819A, U54CA151819, R00CA126184)
- National Institute of General Medical Sciences (GM 076547, P50GM076547)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- P4 medicine, predictive medicine, preventive medicine, personalized medicine, participatory medicine, tumor markers, systems biology, cancer genomics, single-cell analysis, microfluidics, companion diagnostics, precision oncology, tumor recurrence, health care costs, digital health
- MeSH terms
- Humans, Medical Oncology, Mutation, Neoplasms, Biomarkers, Tumor, Genome, Human, Gene Expression Profiling, Genomics, Proteomics, Systems Biology, Precision Medicine, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review